Next, we collected peripheral blood from 12 patients with MSS-CRC (3 with epigenetic-related gene mutations) and measured the proportion of CD8+PD1+T cells and CD3-CD56+CD16+NK cells by flow cytometry. The gene discussed is NCAM1; the disease is colorectal carcinoma.